CNSP - CIK 0001729427
CNS Pharmaceuticals, Inc. trades as CNSP. This page tracks CNS Pharmaceuticals, Inc. through 379 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| EFFECT | - | 2026-05-26 |
| 424B3 | - | 2026-05-26 |
| Insider trade | 4 | 2026-05-20 |
| D | - | 2026-05-19 |
| Securities registration | S-3 | 2026-05-19 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-14 |
| Major company event | 8-K | 2026-05-04 |
The largest companies sharing CNS Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year CNS Pharmaceuticals, Inc. reported a net loss of $15.85M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.